NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
01/26/2024
Back to search
Official data from USPTO
P³ PATIENTS PHARMACISTS PARTNERSHIPS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
01/26/2024
Classification
Registered
Trademark type
Combined
Nice classes
41, 44
Filing date
03/26/2012
Registration date
08/27/2013
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/26/2024
Last transaction
01/26/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
01/01/2009
First use in commerce
01/01/2009
Drawing code
3
Owner type
14
Owner location
Baltimore, MD
Examiner
SOMERVILLE, ARETHA
Law office
L70
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of the capital letter "P" with a raised number "3" and the words "patients pharmacists partnerships".
Holders and representatives
Holders
U. B. (pessoa física)
Representatives
University of Maryland Baltimore
Technical classification
Nice Classes
Class 41Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Educational services, namely, developing, arranging for and conducting health education and chronic disease self-management programs using pharmacists to provide guidance in the fields of medication review, disease management, adherence, lifestyle changes, and self-care skills; developing and arranging for and providing seminars, conferences and workshops in the fields of chronic disease management and medication review and distributing curricula, course, seminar, conference and workshop materials in connections therewith; developing educational materials, namely, curricula, for others; conducting educational demonstrations, research and testing; organizing exhibitions in the nature of exhibits for educational purposes and conducting educational programs, namely, lectures in the fields of chronic disease management and medication review
Class 44
Consulting services in the fields of medication review and chronic disease management programs; pharmaceutical consultation, namely, pharmacist medication review and disease management advice to individuals, employers, patient care teams, medication and healthcare benefits providers
Publications
History of USPTO decisions and trademark events.
35 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
01/26/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
01/26/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/26/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
07/31/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/27/2022
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
09/13/2019
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
09/13/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/13/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/27/2019
ES8R
TEAS SECTION 8 RECEIVED
08/27/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/27/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
08/27/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/11/2013
PUBO
PUBLISHED FOR OPPOSITION
06/11/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/22/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/08/2013
ALIE
ASSIGNED TO LIE
05/06/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/28/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/18/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/18/2013
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/18/2013
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/30/2013
GNFR
FINAL REFUSAL E-MAILED
01/30/2013
CNFR
FINAL REFUSAL WRITTEN
01/30/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/19/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/19/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/19/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/11/2012
GNRT
NON-FINAL ACTION E-MAILED
07/11/2012
CNRT
NON-FINAL ACTION WRITTEN
07/11/2012
DOCK
ASSIGNED TO EXAMINER
06/29/2012
MDSM
NOTICE OF DESIGN SEARCH CODE MAILED
04/04/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/03/2012
NWAP
NEW APPLICATION ENTERED
03/29/2012
Continuous trademark protection
Get notified about every new filing that threatens P³ PATIENTS PHARMACISTS PARTNERSHIPS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.